Bicycle Therapeutics (BCYC) Stock Price Target 2026

The average analyst price target for Bicycle Therapeutics is $20.38, 477.1% above the current price. Of 12 analysts, 9 rate it Buy and 3 Hold. Targets range from $7 to $60. The latest change came on Jul 30, 2026, when Needham lowered its price target on Bicycle Therapeutics from $15 to $14 and kept a Buy rating.